Sharechat Logo

Fonterra capital plan leaves Fitch unmoved

Friday 18th September 2009

Text too small?

Capital restructuring plans announced by the New Zealand dairy cooperative, Fonterra, will have no impact on its AA- credit rating, despite improving the business's ability to manage risk of share redemptions by farmer members in bad years, says the Fitch Ratings agency.

The first two elements of the restructuring plan - allowing farmers to buy equity equivalent to 120% of their on-farm milk production, and reforming the Fair Value Share calculation to account for the fact that only farmer-members can hold Fonterra shares - were positive, Fitch said.

While there would now be incentives created to hold rather than redeem shares, and to sell over-production to other milk processors rather than Fonterra in bad years, the dilution effect was "minimal (estimated at between NZD0.01-NZD0.02) and is considered unlikely to materially impact Fonterra's share of total milk collection".

 "However the proposed changes do not increase the level of subordination to other creditors nor significantly increase Fonterra's ability to raise equity capital, both of which are fundamental to Fonterra's rating," Fitch said.

 

 

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors